<bill session="119" type="h" number="1414" updated="2025-11-19T09:06:55Z">
  <state datetime="2025-02-18">REFERRED</state>
  <status>
    <introduced datetime="2025-02-18"/>
  </status>
  <introduced datetime="2025-02-18"/>
  <titles>
    <title type="display">Cameron&#226;&#8364;&#8482;s Law</title>
    <title type="short" as="introduced">Cameron&#226;&#8364;&#8482;s Law</title>
    <title type="official" as="introduced">To amend the Internal Revenue Code of 1986 to restore the amount of the orphan drug tax credit.</title>
  </titles>
  <sponsor bioguide_id="G000583"/>
  <cosponsors>
    <cosponsor bioguide_id="B001298" joined="2025-02-18"/>
    <cosponsor bioguide_id="C001126" joined="2025-03-24"/>
    <cosponsor bioguide_id="C001072" joined="2025-11-18"/>
    <cosponsor bioguide_id="C001059" joined="2025-09-30"/>
    <cosponsor bioguide_id="C001063" joined="2025-08-08"/>
    <cosponsor bioguide_id="D000230" joined="2025-04-10"/>
    <cosponsor bioguide_id="F000466" joined="2025-02-26"/>
    <cosponsor bioguide_id="J000288" joined="2025-04-07"/>
    <cosponsor bioguide_id="K000376" joined="2025-10-24"/>
    <cosponsor bioguide_id="K000397" joined="2025-10-21"/>
    <cosponsor bioguide_id="L000599" joined="2025-07-10"/>
    <cosponsor bioguide_id="M001222" joined="2025-02-25"/>
    <cosponsor bioguide_id="P000613" joined="2025-02-18"/>
    <cosponsor bioguide_id="S001190" joined="2025-09-15"/>
    <cosponsor bioguide_id="S001201" joined="2025-02-18"/>
  </cosponsors>
  <actions>
    <action datetime="2025-02-18">
      <text>Introduced in House</text>
    </action>
    <action datetime="2025-02-18" state="REFERRED">
      <text>Referred to the House Committee on Ways and Means.</text>
    </action>
  </actions>
  <committees>
    <committee code="HSWM" name="House Ways and Means" subcommittee="" activity="Referred To"/>
  </committees>
  <relatedbills/>
  <subjects>
    <term name="Taxation"/>
  </subjects>
  <amendments/>
  <summary date="2025-09-18T14:08:02Z" status="Introduced in House">Cameron's Law

This bill increases the orphan drug tax credit to 50% (from 25%) of qualified clinical testing expenses paid or incurred in the development of drugs to treat certain rare diseases or conditions.

As background, the Tax Cuts and Jobs Act reduced the orphan drug tax credit (for tax years after 2017) to 25% of qualified clinical testing&#160;expenses (e.g., wages, supplies, and certain contract expenses) paid or incurred in the development of drugs to treat certain rare diseases or conditions. For 2017 and prior tax years, the orphan tax credit was 50% of such expenses paid or incurred.</summary>
</bill>
